Actively Recruiting
Study of Phage Therapy Requests for Bone Infection at Hospices Civils de Lyon from 2015 to 2028
Led by Hospices Civils de Lyon · Updated on 2023-06-01
1500
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting the Avis-PHAGEinLYON Clinic study at a single site to observe patients referred to the Hospices Civils de Lyon for medical advice regarding phage therapy between 2015 and 2028. The goal is to count how many requests for phage therapy the clinic receives, focusing on patients with bone infections. This is a non-interventional study, meaning no treatments are assigned as part of the research. The study involves collecting information from up to 1500 patients who have been referred for phage therapy consideration during the specified period. There are no treatment interventions instead, the study documents the number and characteristics of phage therapy requests made to the clinic. This data collection covers both past and ongoing patient referrals. Participants will be included based on their referral history and will receive information about the study. The main measure is the number of phage therapy requests at the time of inclusion. There are no additional procedures, treatments, or follow-up visits required, and participants usual medical care continues as normal throughout the study.
CONDITIONS
Brief Title
Avis-PHAGEinLYON Clinic
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient referred to the Hospices Civils de Lyon for a phage therapy request from 01/01/2015 to 01/01/2028
- Patient has been provided with information about the Avis-PHAGEinLYON clinic study
You will not qualify if you...
- Patient opposes participation in the study
Research Team
T
Tristan FERRY, MD
M
Myrtille LE BOUAR, CRA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here